Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 13

1.

The second messenger c-di-AMP inhibits the osmolyte uptake system OpuC in Staphylococcus aureus.

Schuster CF, Bellows LE, Tosi T, Campeotto I, Corrigan RM, Freemont P, Gründling A.

Sci Signal. 2016 Aug 16;9(441):ra81. doi: 10.1126/scisignal.aaf7279.

2.

Binding of Cyclic Di-AMP to the Staphylococcus aureus Sensor Kinase KdpD Occurs via the Universal Stress Protein Domain and Downregulates the Expression of the Kdp Potassium Transporter.

Moscoso JA, Schramke H, Zhang Y, Tosi T, Dehbi A, Jung K, Gründling A.

J Bacteriol. 2015 Jul 20;198(1):98-110. doi: 10.1128/JB.00480-15. Print 2016 Jan 1.

3.

Structural similarity of secretins from type II and type III secretion systems.

Tosi T, Estrozi LF, Job V, Guilvout I, Pugsley AP, Schoehn G, Dessen A.

Structure. 2014 Sep 2;22(9):1348-1355. doi: 10.1016/j.str.2014.07.005. Epub 2014 Aug 21.

4.

Structural basis of eukaryotic cell targeting by type III secretion system (T3SS) effectors.

Tosi T, Pflug A, Discola KF, Neves D, Dessen A.

Res Microbiol. 2013 Jul-Aug;164(6):605-19. doi: 10.1016/j.resmic.2013.03.019. Epub 2013 Mar 26. Review.

PMID:
23541478
5.

Structural insights into Helicobacter pylori oncoprotein CagA interaction with β1 integrin.

Kaplan-Türköz B, Jiménez-Soto LF, Dian C, Ertl C, Remaut H, Louche A, Tosi T, Haas R, Terradot L.

Proc Natl Acad Sci U S A. 2012 Sep 4;109(36):14640-5. doi: 10.1073/pnas.1206098109. Epub 2012 Aug 20.

6.

Pilotin-secretin recognition in the type II secretion system of Klebsiella oxytoca.

Tosi T, Nickerson NN, Mollica L, Jensen MR, Blackledge M, Baron B, England P, Pugsley AP, Dessen A.

Mol Microbiol. 2011 Dec;82(6):1422-32. doi: 10.1111/j.1365-2958.2011.07896.x. Epub 2011 Nov 21.

7.

Outer membrane targeting of secretin PulD protein relies on disordered domain recognition by a dedicated chaperone.

Nickerson NN, Tosi T, Dessen A, Baron B, Raynal B, England P, Pugsley AP.

J Biol Chem. 2011 Nov 11;286(45):38833-43. doi: 10.1074/jbc.M111.279851. Epub 2011 Aug 30.

8.

Structures of the tumor necrosis factor alpha inducing protein Tipalpha: a novel virulence factor from Helicobacter pylori.

Tosi T, Cioci G, Jouravleva K, Dian C, Terradot L.

FEBS Lett. 2009 May 19;583(10):1581-5. doi: 10.1016/j.febslet.2009.04.033. Epub 2009 May 4.

9.

Expression of Helicobacter pylori CagA domains by library-based construct screening.

Angelini A, Tosi T, Mas P, Acajjaoui S, Zanotti G, Terradot L, Hart DJ.

FEBS J. 2009 Feb;276(3):816-24. doi: 10.1111/j.1742-4658.2008.06826.x.

10.
11.

New potent antihyperglycemic agents in db/db mice: synthesis and structure-activity relationship studies of (4-substituted benzyl) (trifluoromethyl)pyrazoles and -pyrazolones.

Kees KL, Fitzgerald JJ Jr, Steiner KE, Mattes JF, Mihan B, Tosi T, Mondoro D, McCaleb ML.

J Med Chem. 1996 Sep 27;39(20):3920-8.

PMID:
8831758
12.

[Post-traumatic chyluria. Presentation of a clinico-radiologic case].

Castiglioni G, Tosi T, Castiglioni G, Enriù P.

Radiol Med. 1993 Sep;86(3):368-70. Italian. No abstract available.

PMID:
8210555
13.

Mental retardation associated with an unusual amino acid excretion pattern.

Daniel WL, Tosi T.

Clin Genet. 1974;6(1):60-5. No abstract available.

PMID:
4426131

Supplemental Content

Support Center